Outcome of Kidney Transplantation Following End-Stage Renal Disease Due to Reflux Nephropathy

被引:10
|
作者
Yazici, H. [1 ]
Caliskan, Y. [1 ]
Ozturk, S. [1 ]
Ozkan, O. [1 ]
Turkmen, A. [1 ]
Sever, M. S. [1 ]
机构
[1] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Nephrol, Istanbul, Turkey
关键词
VESICOURETERAL REFLUX;
D O I
10.1016/j.transproceed.2011.01.181
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Reflux nephropathy (RN) has an important place among the etiologies of end-stage renal disease (ESRD). In this retrospective study we sought to analyze posttransplantation complications among renal transplant recipients whose primary disease was RN. Methods. Seven hundred forty-five patients who underwent transplantation in our institution between 1983 and 2006 were included in the study. The outcomes of patients with RN (Group 1) were compared with a control group (Group 2) that consisted of age-matched, nondiabetic patients whose primary disease was chronic glomerulonephritis or unknown etiologies. Results. Group 1 consisted of 52 patients, including 20 males with a mean overall age of 25 years. Group 2 included 47 patients, including 21 males with a mean age of 27 years. There was no significant difference with regard to age, gender, donor type, donor age, modality of hemodialysis, or HI-A match between the 2 groups. Group 1 graft survival rates in the first and fifth years were 95% and 90%, respectively, and in Group 2 they were 86% and 70%, respectively (P = .302 and P = .072, respectively). There was no significant difference with respect to follow-up duration, hospital stay, or incidence of biopsy-proven or clinically suspected acute rejection episodes between the groups. During the 6-year follow-up, the incidence of biopsy-proven chronic allograft nephropathy was the same in both groups. One patient in Group 1 and 2 in Group 2 died of cardiovascular issues; 1 Group 2 patient died of infection. The frequency of urinary tract infection in Group 1 was greater than that of Group 2 (40% vs, 23%; P = NS). Conclusion. Despite the higher incidence of urinary tract infections, there was no significant difference in posttransplantation complications or patient and graft survival rates between RN patients compared with the control group.
引用
收藏
页码:1566 / 1569
页数:4
相关论文
共 50 条
  • [1] OUTCOME OF RENAL-TRANSPLANTATION FOR END-STAGE REFLUX NEPHROPATHY
    TORRES, VE
    VELOSA, JA
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1981, 246 (21): : 2430 - 2430
  • [2] Vesicoureteral Reflux, Reflux Nephropathy, and End-Stage Renal Disease
    Brakeman, Paul
    ADVANCES IN UROLOGY, 2008, 2008
  • [3] Posttranplant Urinary Tract Infection Rates and Graft Outcome in Kidney Transplantation for End-Stage Renal Disease Due to Reflux Nephropathy Versus Chronic Glomerulonephritis
    Kara, E.
    Sakaci, T.
    Ahbap, E.
    Sahutoglu, T.
    Koc, Y.
    Basturk, T.
    Sevinc, M.
    Akgol, C.
    Kayalar, A. O.
    Ucar, Z. A.
    Unsal, A.
    Seyahi, N.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (06) : 2065 - 2071
  • [4] END-STAGE REFLUX NEPHROPATHY
    BAILEY, RR
    LYNN, KL
    ROBSON, RA
    RENAL FAILURE, 1994, 16 (01) : 27 - 35
  • [5] END-STAGE REFLUX NEPHROPATHY
    BAILEY, RR
    NEPHRON, 1981, 27 (06): : 302 - 306
  • [6] END-STAGE REFLUX NEPHROPATHY
    BAILEY, RR
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (04): : 467 - 467
  • [7] END-STAGE REFLUX NEPHROPATHY
    BAILEY, RR
    BRITISH JOURNAL OF UROLOGY, 1981, 53 (01): : 72 - 72
  • [8] Duration of end-stage renal disease and kidney transplant outcome
    Goldfarb-Rumyantzev, A
    Hurdle, JF
    Scandling, J
    Wang, Z
    Baird, B
    Barenbaum, L
    Cheung, AK
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (01) : 167 - 175
  • [9] REFLUX NEPHROPATHY AS A CAUSE OF END-STAGE RENAL-FAILURE
    BROWN, JH
    MCGEOWN, MG
    CLINICAL NEPHROLOGY, 1988, 29 (02) : 103 - 104
  • [10] REFLUX NEPHROPATHY AS A CAUSE OF END-STAGE RENAL-FAILURE
    NIYAMATHULLAH, MM
    KAKRE, N
    THOMAS, PP
    JACOB, CK
    KIRUBAKARAN, MG
    GOPALAKRISHNAN, G
    SHASTRY, JCM
    CLINICAL NEPHROLOGY, 1989, 32 (01) : 49 - 49